Table 6 Gender differences in AED utilization
AEDs Monotherapy Polytherapy | Total 593 338 | Male 329 (55.4%) 146 (43.1%) | Female 264 (44.6%) 192 (56.9%) | p value 0.00 |
|---|---|---|---|---|
Distribution of drug prescribed | ||||
Valproate | 514 | 285 (55.4%) | 229 (44.6%) | 0.0005* |
Carbamazepine | 395 | 187 (47.3%) | 208 (52.7%) | 0.001* |
Levetiracetam | 185 | 62 (33.5%) | 123 (66.5%) | 0.001* |
Phenytoin | 129 | 72 (55.8%) | 57 (44.2%) | 0.186 |
Lamotrigine | 68 | 33 (48.5%) | 35 (51.5%) | 0.89 |
Clonazepam | 21 | 11 (52.3%) | 10 (47.6%) | 1.00 |
Oxcarpazepine | 13 | 8 (61.5%) | 5 (38.4%) | 0.57 |
Topiramaye | 11 | 3 (27.3%) | 8 (72.7%) | 0.22 |
Locozamide | 6 | 4 (66.7%) | 2 (33.3%) | 0.68 |
Ethusoxamide | 6 | 3 (50%) | 3 (50%) | 1.00 |